PMID: 6398628Jan 1, 1984Paper

Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial

The American Journal of Pediatric Hematology/oncology
G R Buchanan, C A Holtkamp

Abstract

The efficacy of corticosteroids in childhood acute idiopathic thrombocytopenic purpura (ITP) is controversial and has infrequently been evaluated in a controlled randomized fashion. We administered prednisone (2 mg/kg/day for 14 days with subsequent tapering and discontinuation by day 21) or placebo to 27 children, aged 10 years or less, with newly diagnosed ITP. Platelet count, bleeding time (a test of the integrity of the platelet-microvasculature interaction), and clinical bleeding score (based on a 0-4 scale) were determined before (day 0) and six times following initiation of drug therapy (days 1-2, 3-5, 7, 14, 21, and 28). There were no statistically significant (p less than 0.05) differences between the two treatment groups in any of the three study parameters except on day 7 of therapy when children receiving prednisone had higher platelet counts and lower bleeding scores and bleeding times than those taking placebo. Bleeding time correlated inversely with the platelet count in both treatment groups. Prednisone did not appear to influence bleeding time independent of its effect on platelet count. This treatment regimen of prednisone did not clearly improve hemostasis in childhood acute ITP except transiently at the end ...Continue Reading

Citations

Jan 11, 2002·Lancet·T KühneUNKNOWN Intercontinental Childhood ITP Study Group
Jan 7, 2014·European Journal of Pediatrics·Veerle Labarque, Chris Van Geet
Jun 3, 1999·Transfusion Science·T Kühne, P Imbach
May 1, 1987·Indian Journal of Pediatrics·A Emami
Aug 22, 2008·Indian Journal of Pediatrics·V GuptaB D Bhatia
Mar 1, 1987·European Journal of Pediatrics·G R Buchanan
Mar 29, 2002·The New England Journal of Medicine·Douglas B Cines, Victor S Blanchette
Jan 1, 1987·Critical Reviews in Oncology/hematology·R Ware, T R Kinney
Jan 1, 2009·Pediatric Blood & Cancer·Derya KalyoncuFeyzullah Cetinkaya
Jul 1, 1989·Baillière's Clinical Haematology·S Bellucci
Jul 15, 2015·Pediatric Hematology and Oncology·Inci YildizHilmi Apak
Feb 18, 2003·British Journal of Haematology·UNKNOWN British Committee for Standards in Haematology General Haematology Task Force
May 17, 2013·Seminars in Hematology·Adolfo Flores, George R Buchanan
Nov 1, 2002·The Journal of Pediatrics·George R Buchanan, Leah Adix
Dec 17, 2014·Journal of Thrombosis and Haemostasis : JTH·C NeunertD M Arnold
Sep 1, 1995·Clinical Pediatrics·A K Souid, P D Sadowitz
Dec 12, 2003·Journal of Pediatric Hematology/oncology·George R Buchanan
Mar 29, 2018·Expert Opinion on Pharmacotherapy·Thomas Kühne
Mar 27, 2004·Transfusion·Rachel KorethNigel S Key
Nov 13, 2001·Reviews in Clinical and Experimental Hematology·H Gadner
Oct 31, 2012·Pediatric Blood & Cancer·Adolfo Flores, George R Buchanan
Sep 17, 2013·Pediatric Blood & Cancer·Michael D DeelSalvatore J Bertolone
Oct 16, 2007·Current Opinion in Hematology·Michael D Tarantino, Paula Hb Bolton-Maggs
Apr 20, 2000·Indian Journal of Pediatrics·V P ChoudhryH P Pati
Jul 1, 1987·Acta paediatrica Scandinavica·S RosthøjT K Glud
Jan 24, 2009·Pediatric Blood & Cancer·George B Segel, Stephen A Feig
Oct 11, 2005·Pediatric Emergency Care·Julie A Panepinto, David C Brousseau
Oct 31, 2012·Pediatric Blood & Cancer·Donald M Arnold
Aug 14, 2008·Blood·Cindy E NeunertUNKNOWN Intercontinental Childhood ITP Study Group Registry II Participants
Nov 24, 2005·Hematology·Catherine S Manno
Feb 17, 2000·Current Opinion in Pediatrics·D Medeiros, G R Buchanan
Jul 1, 2006·Brain, Behavior and Evolution·Louis LefebvreSaima Arshad
Mar 30, 2019·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Marianne E NellisOliver Karam
May 1, 1989·European Journal of Haematology·S OzsoyluA Karabent
May 1, 1993·American Journal of Hematology·G M Magbool
Dec 4, 2019·Blood Advances·Cindy NeunertSara K Vesely
Mar 21, 1998·European Journal of Haematology·A OttenA Brand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.